SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-038695
Filing Date
2021-02-11
Accepted
2021-02-11 17:05:59
Documents
2
Group Members
NEW LEAF VENTURE ASSOCIATES III, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G d124364dsc13g.htm SC 13G 106294
2 EX-99.1 d124364dex991.htm EX-99.1 9768
  Complete submission text file 0001193125-21-038695.txt   117865
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Ventures III, L.P. (Filed by) CIK: 0001625653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Subject) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91451 | Film No.: 21620756
SIC: 2836 Biological Products, (No Diagnostic Substances)